Your browser doesn't support javascript.
loading
Sanguinarine inhibits melanoma invasion and migration by targeting the FAK/PI3K/AKT/mTOR signalling pathway.
Qi, Xiaoyi; Chen, Yonglan; Liu, Sha; Liu, Li; Yu, Zehui; Yin, Ling; Fu, Lu; Deng, Mingming; Liang, Sicheng; Lü, Muhan.
Afiliación
  • Qi X; Department of Gastroenterology, The Affiliated Hospital of Southwest Medical University, Luzhou, China.
  • Chen Y; Department of Dermatology, The Affiliated Hospital of Southwest Medical University, Luzhou, China.
  • Liu S; The Public Platform of Advanced Detecting Instruments, Public Center of Experimental Technology, Southwest Medical University, Luzhou, China.
  • Liu L; Human Microecology and Precision Diagnosis and Treatment of Luzhou Key Laboratory, Luzhou, China.
  • Yu Z; Cardiovascular and Metabolic Diseases of Sichuan Key Laboratory, Luzhou, China.
  • Yin L; Institute of Drug Metabolism and Pharmaceutical Analysis, Zhejiang University, Hangzhou, China.
  • Fu L; Department of Gastroenterology, The Affiliated Hospital of Southwest Medical University, Luzhou, China.
  • Deng M; Department of Gastroenterology, The Affiliated Hospital of Southwest Medical University, Luzhou, China.
  • Liang S; Department of Gastroenterology, The Affiliated Hospital of Southwest Medical University, Luzhou, China.
  • Lü M; Department of Gastroenterology, The Affiliated Hospital of Southwest Medical University, Luzhou, China.
Pharm Biol ; 61(1): 696-709, 2023 Dec.
Article en En | MEDLINE | ID: mdl-37092313
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Proteínas Proto-Oncogénicas c-akt / Melanoma Límite: Animals / Humans Idioma: En Revista: Pharm Biol Año: 2023 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Proteínas Proto-Oncogénicas c-akt / Melanoma Límite: Animals / Humans Idioma: En Revista: Pharm Biol Año: 2023 Tipo del documento: Article País de afiliación: China